RT Journal Article
SR Electronic
T1 A modular approach to integrating multiple data sources into real-time clinical prediction for pediatric diarrhea
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.26.20210385
DO 10.1101/2020.10.26.20210385
A1 Brintz, Ben J.
A1 Haaland, Benjamin
A1 Howard, Joel
A1 Chao, Dennis L.
A1 Proctor, Joshua L.
A1 Khan, Ashraful I.
A1 Ahmed, Sharia M.
A1 Keegan, Lindsay T.
A1 Greene, Tom
A1 Keita, Adama Mamby
A1 Kotloff, Karen L.
A1 Platts-Mills, James A.
A1 Nelson, Eric J.
A1 Levine, Adam C.
A1 Pavia, Andrew T.
A1 Leung, Daniel T.
YR 2020
UL http://medrxiv.org/content/early/2020/10/27/2020.10.26.20210385.abstract
AB Traditional clinical prediction models focus on parameters of the individual patient. For infectious diseases, sources external to the patient, including characteristics of prior patients and seasonal factors, may improve predictive performance. We describe the development of a predictive model that integrates multiple sources of data in a principled statistical framework using a post-test odds formulation. Our method enables electronic real-time updating and flexibility, such that components can be included or excluded according to data availability. We apply this method to the prediction of etiology of pediatric diarrhea, where “pre-test” epidemiologic data may be highly informative. Diarrhea has a high burden in low-resource settings, and antibiotics are often over-prescribed. We demonstrate that our integrative method outperforms traditional prediction in accurately identifying cases with a viral etiology, and show that its clinical application, especially when used with an additional diagnostic test, could result in a 61% reduction in inappropriately prescribed antibiotics.Competing Interest StatementATP has received royalties from Antimicrobial Therapy Inc. and consulting fees from Merck, Genentech and Sequirius, unrelated to the current work.Funding StatementNational Center for Advancing Translational Sciences (NCATS) Valid : Benjamin Brintz, Benjamin Haaland, Tom Greene 8UL1TR000105 National Institute of Allergy and Infectious Diseases (NIAID) Valid : Daniel T Leung R01AI135114 Bill and Melinda Gates Foundation (BMGF) Valid : Daniel T Leung OPP1198876 The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The GEMS study protocol was approved by ethics committees at the University of Maryland, Baltimore and at each field site. Parents or caregivers of participants provided written informed consent, and a witnessed consent was obtained for illiterate parents or caretakers.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData Availability: GEMS data are available to the public from https://clinepidb.org/ce/app/. Data and code needed to reproduce all parts of this analysis are available from the corresponding author's GitHub page: https://github.com/LeungLab/GEMS_PostTestOdds https://github.com/LeungLab/GEMS_PostTestOdds